PhRMA launches new legal challenge as CMS brings 'most favored nation' pricing to Medicare Part B
As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, the pharmaceutical industry’s top lobbying group is pushing back in court.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.